Summary
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blood cell counts. It is not recommended in people with kidney problems. Use during pregnancy may result in harm to the baby. Capecitabine, inside the body, is converted to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications known as fluoropyrimidines, which also includes 5-fluorouracil and tegafur.
According to APO Research, The global Capecitabine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Capecitabine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Capecitabine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Capecitabine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Capecitabine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Capecitabine include Roche, Teva, Mylan, Hikma, Hengrui Medicine, Cipla, Reliance Group and Hetero, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Capecitabine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Capecitabine, also provides the sales of main regions and countries. Of the upcoming market potential for Capecitabine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Capecitabine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Capecitabine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Capecitabine sales, projected growth trends, production technology, application and end-user industry.
Capecitabine segment by Company
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Capecitabine segment by Type
500 mg
150 mg
Capecitabine segment by Application
Breast Cancer
Colorectal Cancer
Stomach Cancer
Capecitabine segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Capecitabine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Capecitabine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Capecitabine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Capecitabine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Capecitabine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Capecitabine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Capecitabine Market by Type
1.2.1 Global Capecitabine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 500 mg
1.2.3 150 mg
1.3 Capecitabine Market by Application
1.3.1 Global Capecitabine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Stomach Cancer
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Capecitabine Market Dynamics
2.1 Capecitabine Industry Trends
2.2 Capecitabine Industry Drivers
2.3 Capecitabine Industry Opportunities and Challenges
2.4 Capecitabine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Capecitabine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Capecitabine Revenue by Region
3.2.1 Global Capecitabine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Capecitabine Revenue by Region (2019-2024)
3.2.3 Global Capecitabine Revenue by Region (2025-2030)
3.2.4 Global Capecitabine Revenue Market Share by Region (2019-2030)
3.3 Global Capecitabine Sales Estimates and Forecasts 2019-2030
3.4 Global Capecitabine Sales by Region
3.4.1 Global Capecitabine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Capecitabine Sales by Region (2019-2024)
3.4.3 Global Capecitabine Sales by Region (2025-2030)
3.4.4 Global Capecitabine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Capecitabine Revenue by Manufacturers
4.1.1 Global Capecitabine Revenue by Manufacturers (2019-2024)
4.1.2 Global Capecitabine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Capecitabine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Capecitabine Sales by Manufacturers
4.2.1 Global Capecitabine Sales by Manufacturers (2019-2024)
4.2.2 Global Capecitabine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Capecitabine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Capecitabine Sales Price by Manufacturers (2019-2024)
4.4 Global Capecitabine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Capecitabine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Capecitabine Manufacturers, Product Type & Application
4.7 Global Capecitabine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Capecitabine Market CR5 and HHI
4.8.2 2023 Capecitabine Tier 1, Tier 2, and Tier 3
5 Capecitabine Market by Type
5.1 Global Capecitabine Revenue by Type
5.1.1 Global Capecitabine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Capecitabine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Capecitabine Revenue Market Share by Type (2019-2030)
5.2 Global Capecitabine Sales by Type
5.2.1 Global Capecitabine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Capecitabine Sales by Type (2019-2030) & (Kg)
5.2.3 Global Capecitabine Sales Market Share by Type (2019-2030)
5.3 Global Capecitabine Price by Type
6 Capecitabine Market by Application
6.1 Global Capecitabine Revenue by Application
6.1.1 Global Capecitabine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Capecitabine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Capecitabine Revenue Market Share by Application (2019-2030)
6.2 Global Capecitabine Sales by Application
6.2.1 Global Capecitabine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Capecitabine Sales by Application (2019-2030) & (Kg)
6.2.3 Global Capecitabine Sales Market Share by Application (2019-2030)
6.3 Global Capecitabine Price by Application
7 Company Profiles
7.1 Roche
7.1.1 Roche Comapny Information
7.1.2 Roche Business Overview
7.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Roche Capecitabine Product Portfolio
7.1.5 Roche Recent Developments
7.2 Teva
7.2.1 Teva Comapny Information
7.2.2 Teva Business Overview
7.2.3 Teva Capecitabine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Teva Capecitabine Product Portfolio
7.2.5 Teva Recent Developments
7.3 Mylan
7.3.1 Mylan Comapny Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mylan Capecitabine Product Portfolio
7.3.5 Mylan Recent Developments
7.4 Hikma
7.4.1 Hikma Comapny Information
7.4.2 Hikma Business Overview
7.4.3 Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Hikma Capecitabine Product Portfolio
7.4.5 Hikma Recent Developments
7.5 Hengrui Medicine
7.5.1 Hengrui Medicine Comapny Information
7.5.2 Hengrui Medicine Business Overview
7.5.3 Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Hengrui Medicine Capecitabine Product Portfolio
7.5.5 Hengrui Medicine Recent Developments
7.6 Cipla
7.6.1 Cipla Comapny Information
7.6.2 Cipla Business Overview
7.6.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Cipla Capecitabine Product Portfolio
7.6.5 Cipla Recent Developments
7.7 Reliance Group
7.7.1 Reliance Group Comapny Information
7.7.2 Reliance Group Business Overview
7.7.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Reliance Group Capecitabine Product Portfolio
7.7.5 Reliance Group Recent Developments
7.8 Hetero
7.8.1 Hetero Comapny Information
7.8.2 Hetero Business Overview
7.8.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Hetero Capecitabine Product Portfolio
7.8.5 Hetero Recent Developments
8 North America
8.1 North America Capecitabine Market Size by Type
8.1.1 North America Capecitabine Revenue by Type (2019-2030)
8.1.2 North America Capecitabine Sales by Type (2019-2030)
8.1.3 North America Capecitabine Price by Type (2019-2030)
8.2 North America Capecitabine Market Size by Application
8.2.1 North America Capecitabine Revenue by Application (2019-2030)
8.2.2 North America Capecitabine Sales by Application (2019-2030)
8.2.3 North America Capecitabine Price by Application (2019-2030)
8.3 North America Capecitabine Market Size by Country
8.3.1 North America Capecitabine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Capecitabine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Capecitabine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Capecitabine Market Size by Type
9.1.1 Europe Capecitabine Revenue by Type (2019-2030)
9.1.2 Europe Capecitabine Sales by Type (2019-2030)
9.1.3 Europe Capecitabine Price by Type (2019-2030)
9.2 Europe Capecitabine Market Size by Application
9.2.1 Europe Capecitabine Revenue by Application (2019-2030)
9.2.2 Europe Capecitabine Sales by Application (2019-2030)
9.2.3 Europe Capecitabine Price by Application (2019-2030)
9.3 Europe Capecitabine Market Size by Country
9.3.1 Europe Capecitabine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Capecitabine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Capecitabine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Capecitabine Market Size by Type
10.1.1 China Capecitabine Revenue by Type (2019-2030)
10.1.2 China Capecitabine Sales by Type (2019-2030)
10.1.3 China Capecitabine Price by Type (2019-2030)
10.2 China Capecitabine Market Size by Application
10.2.1 China Capecitabine Revenue by Application (2019-2030)
10.2.2 China Capecitabine Sales by Application (2019-2030)
10.2.3 China Capecitabine Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Capecitabine Market Size by Type
11.1.1 Asia Capecitabine Revenue by Type (2019-2030)
11.1.2 Asia Capecitabine Sales by Type (2019-2030)
11.1.3 Asia Capecitabine Price by Type (2019-2030)
11.2 Asia Capecitabine Market Size by Application
11.2.1 Asia Capecitabine Revenue by Application (2019-2030)
11.2.2 Asia Capecitabine Sales by Application (2019-2030)
11.2.3 Asia Capecitabine Price by Application (2019-2030)
11.3 Asia Capecitabine Market Size by Country
11.3.1 Asia Capecitabine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Capecitabine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Capecitabine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Capecitabine Market Size by Type
12.1.1 MEALA Capecitabine Revenue by Type (2019-2030)
12.1.2 MEALA Capecitabine Sales by Type (2019-2030)
12.1.3 MEALA Capecitabine Price by Type (2019-2030)
12.2 MEALA Capecitabine Market Size by Application
12.2.1 MEALA Capecitabine Revenue by Application (2019-2030)
12.2.2 MEALA Capecitabine Sales by Application (2019-2030)
12.2.3 MEALA Capecitabine Price by Application (2019-2030)
12.3 MEALA Capecitabine Market Size by Country
12.3.1 MEALA Capecitabine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Capecitabine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Capecitabine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Capecitabine Value Chain Analysis
13.1.1 Capecitabine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Capecitabine Production Mode & Process
13.2 Capecitabine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Capecitabine Distributors
13.2.3 Capecitabine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Capecitabine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. 500 mg Major Manufacturers
Table 3. 150 mg Major Manufacturers
Table 4. Global Capecitabine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Breast Cancer Major Manufacturers
Table 6. Colorectal Cancer Major Manufacturers
Table 7. Stomach Cancer Major Manufacturers
Table 8. Capecitabine Industry Trends
Table 9. Capecitabine Industry Drivers
Table 10. Capecitabine Industry Opportunities and Challenges
Table 11. Capecitabine Industry Restraints
Table 12. Global Capecitabine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Capecitabine Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Capecitabine Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Capecitabine Revenue Market Share by Region (2019-2024)
Table 16. Global Capecitabine Revenue Market Share by Region (2025-2030)
Table 17. Global Capecitabine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Kg)
Table 18. Global Capecitabine Sales by Region (2019-2024) & (Kg)
Table 19. Global Capecitabine Sales by Region (2025-2030) & (Kg)
Table 20. Global Capecitabine Sales Market Share by Region (2019-2024)
Table 21. Global Capecitabine Sales Market Share by Region (2025-2030)
Table 22. Global Capecitabine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Capecitabine Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Capecitabine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Capecitabine Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Capecitabine Sales Price (USD/g) of Manufacturers (2019-2024)
Table 27. Global Capecitabine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Capecitabine Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Capecitabine Manufacturers, Product Type & Application
Table 30. Global Capecitabine Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Capecitabine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Capecitabine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Capecitabine Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Capecitabine Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Capecitabine Revenue Market Share by Type (2019-2024)
Table 37. Global Capecitabine Revenue Market Share by Type (2025-2030)
Table 38. Global Capecitabine Sales by Type 2019 VS 2023 VS 2030 (Kg)
Table 39. Global Capecitabine Sales by Type (2019-2024) & (Kg)
Table 40. Global Capecitabine Sales by Type (2025-2030) & (Kg)
Table 41. Global Capecitabine Sales Market Share by Type (2019-2024)
Table 42. Global Capecitabine Sales Market Share by Type (2025-2030)
Table 43. Global Capecitabine Price by Type (2019-2024) & (USD/g)
Table 44. Global Capecitabine Price by Type (2025-2030) & (USD/g)
Table 45. Global Capecitabine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Capecitabine Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Capecitabine Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Capecitabine Revenue Market Share by Application (2019-2024)
Table 49. Global Capecitabine Revenue Market Share by Application (2025-2030)
Table 50. Global Capecitabine Sales by Application 2019 VS 2023 VS 2030 (Kg)
Table 51. Global Capecitabine Sales by Application (2019-2024) & (Kg)
Table 52. Global Capecitabine Sales by Application (2025-2030) & (Kg)
Table 53. Global Capecitabine Sales Market Share by Application (2019-2024)
Table 54. Global Capecitabine Sales Market Share by Application (2025-2030)
Table 55. Global Capecitabine Price by Application (2019-2024) & (USD/g)
Table 56. Global Capecitabine Price by Application (2025-2030) & (USD/g)
Table 57. Roche Company Information
Table 58. Roche Business Overview
Table 59. Roche Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 60. Roche Capecitabine Product Portfolio
Table 61. Roche Recent Development
Table 62. Teva Company Information
Table 63. Teva Business Overview
Table 64. Teva Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 65. Teva Capecitabine Product Portfolio
Table 66. Teva Recent Development
Table 67. Mylan Company Information
Table 68. Mylan Business Overview
Table 69. Mylan Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 70. Mylan Capecitabine Product Portfolio
Table 71. Mylan Recent Development
Table 72. Hikma Company Information
Table 73. Hikma Business Overview
Table 74. Hikma Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 75. Hikma Capecitabine Product Portfolio
Table 76. Hikma Recent Development
Table 77. Hengrui Medicine Company Information
Table 78. Hengrui Medicine Business Overview
Table 79. Hengrui Medicine Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 80. Hengrui Medicine Capecitabine Product Portfolio
Table 81. Hengrui Medicine Recent Development
Table 82. Cipla Company Information
Table 83. Cipla Business Overview
Table 84. Cipla Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 85. Cipla Capecitabine Product Portfolio
Table 86. Cipla Recent Development
Table 87. Reliance Group Company Information
Table 88. Reliance Group Business Overview
Table 89. Reliance Group Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 90. Reliance Group Capecitabine Product Portfolio
Table 91. Reliance Group Recent Development
Table 92. Hetero Company Information
Table 93. Hetero Business Overview
Table 94. Hetero Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 95. Hetero Capecitabine Product Portfolio
Table 96. Hetero Recent Development
Table 97. North America Capecitabine Revenue by Type (2019-2024) & (US$ Million)
Table 98. North America Capecitabine Revenue by Type (2025-2030) & (US$ Million)
Table 99. North America Capecitabine Sales by Type (2019-2024) & (Kg)
Table 100. North America Capecitabine Sales by Type (2025-2030) & (Kg)
Table 101. North America Capecitabine Sales Price by Type (2019-2024) & (USD/g)
Table 102. North America Capecitabine Sales Price by Type (2025-2030) & (USD/g)
Table 103. North America Capecitabine Revenue by Application (2019-2024) & (US$ Million)
Table 104. North America Capecitabine Revenue by Application (2025-2030) & (US$ Million)
Table 105. North America Capecitabine Sales by Application (2019-2024) & (Kg)
Table 106. North America Capecitabine Sales by Application (2025-2030) & (Kg)
Table 107. North America Capecitabine Sales Price by Application (2019-2024) & (USD/g)
Table 108. North America Capecitabine Sales Price by Application (2025-2030) & (USD/g)
Table 109. North America Capecitabine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 110. North America Capecitabine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 111. North America Capecitabine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 112. North America Capecitabine Sales by Country (2019 VS 2023 VS 2030) & (Kg)
Table 113. North America Capecitabine Sales by Country (2019-2024) & (Kg)
Table 114. North America Capecitabine Sales by Country (2025-2030) & (Kg)
Table 115. North America Capecitabine Sales Price by Country (2019-2024) & (USD/g)
Table 116. North America Capecitabine Sales Price by Country (2025-2030) & (USD/g)
Table 117. US Capecitabine Revenue (2019-2030) & (US$ Million)
Table 118. Canada Capecitabine Revenue (2019-2030) & (US$ Million)
Table 119. Europe Capecitabine Revenue by Type (2019-2024) & (US$ Million)
Table 120. Europe Capecitabine Revenue by Type (2025-2030) & (US$ Million)
Table 121. Europe Capecitabine Sales by Type (2019-2024) & (Kg)
Table 122. Europe Capecitabine Sales by Type (2025-2030) & (Kg)
Table 123. Europe Capecitabine Sales Price by Type (2019-2024) & (USD/g)
Table 124. Europe Capecitabine Sales Price by Type (2025-2030) & (USD/g)
Table 125. Europe Capecitabine Revenue by Application (2019-2024) & (US$ Million)
Table 126. Europe Capecitabine Revenue by Application (2025-2030) & (US$ Million)
Table 127. Europe Capecitabine Sales by Application (2019-2024) & (Kg)
Table 128. Europe Capecitabine Sales by Application (2025-2030) & (Kg)
Table 129. Europe Capecitabine Sales Price by Application (2019-2024) & (USD/g)
Table 130. Europe Capecitabine Sales Price by Application (2025-2030) & (USD/g)
Table 131. Europe Capecitabine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 132. Europe Capecitabine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 133. Europe Capecitabine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 134. Europe Capecitabine Sales by Country (2019 VS 2023 VS 2030) & (Kg)
Table 135. Europe Capecitabine Sales by Country (2019-2024) & (Kg)
Table 136. Europe Capecitabine Sales by Country (2025-2030) & (Kg)
Table 137. Europe Capecitabine Sales Price by Country (2019-2024) & (USD/g)
Table 138. Europe Capecitabine Sales Price by Country (2025-2030) & (USD/g)
Table 139. Germany Capecitabine Revenue (2019-2030) & (US$ Million)
Table 140. France Capecitabine Revenue (2019-2030) & (US$ Million)
Table 141. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 142. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 143. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 144. China Capecitabine Revenue by Type (2019-2024) & (US$ Million)
Table 145. China Capecitabine Revenue by Type (2025-2030) & (US$ Million)
Table 146. China Capecitabine Sales by Type (2019-2024) & (Kg)
Table 147. China Capecitabine Sales by Type (2025-2030) & (Kg)
Table 148. China Capecitabine Sales Price by Type (2019-2024) & (USD/g)
Table 149. China Capecitabine Sales Price by Type (2025-2030) & (USD/g)
Table 150. China Capecitabine Revenue by Application (2019-2024) & (US$ Million)
Table 151. China Capecitabine Revenue by Application (2025-2030) & (US$ Million)
Table 152. China Capecitabine Sales by Application (2019-2024) & (Kg)
Table 153. China Capecitabine Sales by Application (2025-2030) & (Kg)
Table 154. China Capecitabine Sales Price by Application (2019-2024) & (USD/g)
Table 155. China Capecitabine Sales Price by Application (2025-2030) & (USD/g)
Table 156. Asia Capecitabine Revenue by Type (2019-2024) & (US$ Million)
Table 157. Asia Capecitabine Revenue by Type (2025-2030) & (US$ Million)
Table 158. Asia Capecitabine Sales by Type (2019-2024) & (Kg)
Table 159. Asia Capecitabine Sales by Type (2025-2030) & (Kg)
Table 160. Asia Capecitabine Sales Price by Type (2019-2024) & (USD/g)
Table 161. Asia Capecitabine Sales Price by Type (2025-2030) & (USD/g)
Table 162. Asia Capecitabine Revenue by Application (2019-2024) & (US$ Million)
Table 163. Asia Capecitabine Revenue by Application (2025-2030) & (US$ Million)
Table 164. Asia Capecitabine Sales by Application (2019-2024) & (Kg)
Table 165. Asia Capecitabine Sales by Application (2025-2030) & (Kg)
Table 166. Asia Capecitabine Sales Price by Application (2019-2024) & (USD/g)
Table 167. Asia Capecitabine Sales Price by Application (2025-2030) & (USD/g)
Table 168. Asia Capecitabine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 169. Asia Capecitabine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 170. Asia Capecitabine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 171. Asia Capecitabine Sales by Country (2019 VS 2023 VS 2030) & (Kg)
Table 172. Asia Capecitabine Sales by Country (2019-2024) & (Kg)
Table 173. Asia Capecitabine Sales by Country (2025-2030) & (Kg)
Table 174. Asia Capecitabine Sales Price by Country (2019-2024) & (USD/g)
Table 175. Asia Capecitabine Sales Price by Country (2025-2030) & (USD/g)
Table 176. Japan Capecitabine Revenue (2019-2030) & (US$ Million)
Table 177. South Korea Capecitabine Revenue (2019-2030) & (US$ Million)
Table 178. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 179. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 180. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 181. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 182. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 183. Capecitabine Revenue (2019-2030) & (US$ Million)
Table 184. MEALA Capecitabine Revenue by Type (2019-2024) & (US$ Million)
Table 185. MEALA Capecitabine Revenue by Type (2025-2030) & (US$ Million)
Table 186. MEALA Capecitabine Sales by Type (2019-2024) & (Kg)
Table 187. MEALA Capecitabine Sales by Type (2025-2030) & (Kg)
Table 188. MEALA Capecitabine Sales Price by Type (2019-2024) & (USD/g)
Table 189. MEALA Capecitabine Sales Price by Type (2025-2030) & (USD/g)
Table 190. MEALA Capecitabine Revenue by Application (2019-2024) & (US$ Million)
Table 191. MEALA Capecitabine Revenue by Application (2025-2030) & (US$ Million)
Table 192. MEALA Capecitabine Sales by Application (2019-2024) & (Kg)
Table 193. MEALA Capecitabine Sales by Application (2025-2030) & (Kg)
Table 194. MEALA Capecitabine Sales Price by Application (2019-2024) & (USD/g)
Table 195. MEALA Capecitabine Sales Price by Application (2025-2030) & (USD/g)
Table 196. MEALA Capecitabine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 197. MEALA Capecitabine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 198. MEALA Capecitabine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 199. MEALA Capecitabine Sales by Country (2019 VS 2023 VS 2030) & (Kg)
Table 200. MEALA Capecitabine Sales by Country (2019-2024) & (Kg)
Table 201. MEALA Capecitabine Sales by Country (2025-2030) & (Kg)
Table 202. MEALA Capecitabine Sales Price by Country (2019-2024) & (USD/g)
Table 203. MEALA Capecitabine Sales Price by Country (2025-2030) & (USD/g)
Table 204. Mexico Capecitabine Revenue (2019-2030) & (US$ Million)
Table 205. Brazil Capecitabine Revenue (2019-2030) & (US$ Million)
Table 206. Israel Capecitabine Revenue (2019-2030) & (US$ Million)
Table 207. Argentina Capecitabine Revenue (2019-2030) & (US$ Million)
Table 208. Colombia Capecitabine Revenue (2019-2030) & (US$ Million)
Table 209. Turkey Capecitabine Revenue (2019-2030) & (US$ Million)
Table 210. Saudi Arabia Capecitabine Revenue (2019-2030) & (US$ Million)
Table 211. UAE Capecitabine Revenue (2019-2030) & (US$ Million)
Table 212. Key Raw Materials
Table 213. Raw Materials Key Suppliers
Table 214. Capecitabine Distributors List
Table 215. Capecitabine Customers List
Table 216. Research Programs/Design for This Report
Table 217. Authors List of This Report
Table 218. Secondary Sources
Table 219. Primary Sources
List of Figures
Figure 1. Capecitabine Product Picture
Figure 2. Global Capecitabine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Capecitabine Market Size Share 2019 VS 2023 VS 2030
Figure 4. 500 mg Picture
Figure 5. 150 mg Picture
Figure 6. Global Capecitabine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Capecitabine Market Size Share 2019 VS 2023 VS 2030
Figure 8. Breast Cancer Picture
Figure 9. Colorectal Cancer Picture
Figure 10. Stomach Cancer Picture
Figure 11. Global Capecitabine Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Capecitabine Revenue (2019-2030) & (US$ Million)
Figure 13. Global Capecitabine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 14. Global Capecitabine Revenue Market Share by Region: 2023 Versus 2030
Figure 15. Global Capecitabine Revenue Market Share by Region (2019-2030)
Figure 16. Global Capecitabine Sales (2019-2030) & (Kg)
Figure 17. Global Capecitabine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 18. Global Capecitabine Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Capecitabine Sales YoY (2019-2030) & (Kg)
Figure 20. Europe Capecitabine Sales YoY (2019-2030) & (Kg)
Figure 21. China Capecitabine Sales YoY (2019-2030) & (Kg)
Figure 22. Asia (Excluding China) Capecitabine Sales YoY (2019-2030) & (Kg)
Figure 23. Middle East, Africa and Latin America (Excluding China) Capecitabine Sales YoY (2019-2030) & (Kg)
Figure 24. Global Capecitabine Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 25. Global Capecitabine Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Global Capecitabine Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Capecitabine Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 29. Global Capecitabine Revenue Market Share by Type (2019-2030)
Figure 30. Global Capecitabine Sales by Type (2019 VS 2023 VS 2030) & (Kg)
Figure 31. Global Capecitabine Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 32. Global Capecitabine Sales Market Share by Type (2019-2030)
Figure 33. Global Capecitabine Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 34. Global Capecitabine Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 35. Global Capecitabine Revenue Market Share by Application (2019-2030)
Figure 36. Global Capecitabine Sales by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 37. Global Capecitabine Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 38. Global Capecitabine Sales Market Share by Application (2019-2030)
Figure 39. North America Capecitabine Revenue Share by Type (2019-2030)
Figure 40. North America Capecitabine Sales Share by Type (2019-2030)
Figure 41. North America Capecitabine Revenue Share by Application (2019-2030)
Figure 42. North America Capecitabine Sales Share by Application (2019-2030)
Figure 43. North America Capecitabine Revenue Share by Country (2019-2030)
Figure 44. North America Capecitabine Sales Share by Country (2019-2030)
Figure 45. Europe Capecitabine Revenue Share by Type (2019-2030)
Figure 46. Europe Capecitabine Sales Share by Type (2019-2030)
Figure 47. Europe Capecitabine Revenue Share by Application (2019-2030)
Figure 48. Europe Capecitabine Sales Share by Application (2019-2030)
Figure 49. Europe Capecitabine Revenue Share by Country (2019-2030)
Figure 50. Europe Capecitabine Sales Share by Country (2019-2030)
Figure 51. China Capecitabine Revenue Share by Type (2019-2030)
Figure 52. China Capecitabine Sales Share by Type (2019-2030)
Figure 53. China Capecitabine Revenue Share by Application (2019-2030)
Figure 54. China Capecitabine Sales Share by Application (2019-2030)
Figure 55. Asia Capecitabine Revenue Share by Type (2019-2030)
Figure 56. Asia Capecitabine Sales Share by Type (2019-2030)
Figure 57. Asia Capecitabine Revenue Share by Application (2019-2030)
Figure 58. Asia Capecitabine Sales Share by Application (2019-2030)
Figure 59. Asia Capecitabine Revenue Share by Country (2019-2030)
Figure 60. Asia Capecitabine Sales Share by Country (2019-2030)
Figure 61. MEALA Capecitabine Revenue Share by Type (2019-2030)
Figure 62. MEALA Capecitabine Sales Share by Type (2019-2030)
Figure 63. MEALA Capecitabine Revenue Share by Application (2019-2030)
Figure 64. MEALA Capecitabine Sales Share by Application (2019-2030)
Figure 65. MEALA Capecitabine Revenue Share by Country (2019-2030)
Figure 66. MEALA Capecitabine Sales Share by Country (2019-2030)
Figure 67. Capecitabine Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Capecitabine Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
